These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 5120292

  • 1. Carcinogenicity of derivatives of 7,12-dimethylbenz(a)anthracene.
    Flesher JW, Sydnor KL.
    Cancer Res; 1971 Dec; 31(12):1951-4. PubMed ID: 5120292
    [No Abstract] [Full Text] [Related]

  • 2. Carcinogenicity and mutagenicity of the 3,4-dihydrodiols and other metabolites of 7,12-dimethylbenz(a)anthracene and its hydroxymethyl derivatives.
    Wislocki PG, Gadek KM, Chou MW, Yang SK, Lu AY.
    Cancer Res; 1980 Oct; 40(10):3661-4. PubMed ID: 6777036
    [No Abstract] [Full Text] [Related]

  • 3. Activity of 6-methyl-8-substituted ergolines against the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma.
    Sweeney MJ, Poore GA, Kornfeld EC, Bach NJ, Owen NV, Clemens JA.
    Cancer Res; 1975 Jan; 35(1):106-9. PubMed ID: 1109784
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of a 7,12-dimethylbenz(alpha)anthracene-induced, transplantable, hormone-sensitive mammary tumor in the rat.
    Gala RR, Peck SL.
    J Natl Cancer Inst; 1974 Nov; 53(5):1289-93. PubMed ID: 4431052
    [No Abstract] [Full Text] [Related]

  • 8. Exceptional carcinogenic activity of benz[a]anthracene 3,4-dihydrodiol in the newborn mouse and the bay region theory.
    Wislocki PG, Kapitulnik J, Levin W, Lehr R, Schaefer-Ridder M, Karle JM, Jerina DM, Conney AH.
    Cancer Res; 1978 Mar; 38(3):693-6. PubMed ID: 626973
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Toxicity and cancerogenic activity of a series of 7,12-dimethylbenz(a)anthracene derivatives].
    Adrianov LA, Belitskiĭ GA, Zavadina SP, Shabad LM.
    Vopr Onkol; 1972 Mar; 18(1):54-8. PubMed ID: 5017176
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vivo inhibition of tumor growth by cyclic adenosine 3',5'-monophosphate derivatives.
    Cho-Chung YS.
    Cancer Res; 1974 Dec; 34(12):3492-6. PubMed ID: 4371966
    [No Abstract] [Full Text] [Related]

  • 14. Mutagenicity and tumor-initiating activity of fluorinated derivatives of 7,12-dimethylbenz(a)anthracene.
    Huberman E, Slaga TJ.
    Cancer Res; 1979 Feb; 39(2 Pt 1):411-4. PubMed ID: 104789
    [No Abstract] [Full Text] [Related]

  • 15. Carcinogenicity and polarographic behavior of dibenz[a,h]anthracene, dibenz[a,h]acridine and dibenz[a,h]phenazine.
    Bahna L, Podaný V, Benesová M, Godál A, Vachálková A.
    Neoplasma; 1978 Feb; 25(6):641-5. PubMed ID: 752112
    [Abstract] [Full Text] [Related]

  • 16. Evidence that benzo(a)anthracene 3,4-diol-1,2-epoxide is an ultimate carcinogen on mouse skin.
    Levin W, Thakker DR, Wood AW, Chang RL, Lehr RE, Jerina DM, Conney AH.
    Cancer Res; 1978 Jun; 38(6):1705-10. PubMed ID: 647681
    [No Abstract] [Full Text] [Related]

  • 17. Carcinogenicity of benzo(a) anthracene and benz(c)phenanthrene derivatives.
    Stevenson JL, Von Haam E.
    Am Ind Hyg Assoc J; 1965 Jun; 26(5):475-8. PubMed ID: 5865317
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.